DK0537007T3 - Anvendelse af farnesyl-protein-transferase-inhibitorer til fremstilling af et lægemiddel til blokering af neoplastisk transformation af celler fremkaldt af ras-oncogener - Google Patents

Anvendelse af farnesyl-protein-transferase-inhibitorer til fremstilling af et lægemiddel til blokering af neoplastisk transformation af celler fremkaldt af ras-oncogener

Info

Publication number
DK0537007T3
DK0537007T3 DK92309184.7T DK92309184T DK0537007T3 DK 0537007 T3 DK0537007 T3 DK 0537007T3 DK 92309184 T DK92309184 T DK 92309184T DK 0537007 T3 DK0537007 T3 DK 0537007T3
Authority
DK
Denmark
Prior art keywords
drug
prepare
cells induced
protein transferase
transferase inhibitors
Prior art date
Application number
DK92309184.7T
Other languages
English (en)
Inventor
Scott A Biller
Mariano Barbacid
David R Magnin
Eric M Gordon
Chester A Meyers
Veerasway Manne
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25102836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0537007(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of DK0537007T3 publication Critical patent/DK0537007T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92309184.7T 1991-10-11 1992-10-08 Anvendelse af farnesyl-protein-transferase-inhibitorer til fremstilling af et lægemiddel til blokering af neoplastisk transformation af celler fremkaldt af ras-oncogener DK0537007T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77495791A 1991-10-11 1991-10-11

Publications (1)

Publication Number Publication Date
DK0537007T3 true DK0537007T3 (da) 1995-09-25

Family

ID=25102836

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92309184.7T DK0537007T3 (da) 1991-10-11 1992-10-08 Anvendelse af farnesyl-protein-transferase-inhibitorer til fremstilling af et lægemiddel til blokering af neoplastisk transformation af celler fremkaldt af ras-oncogener

Country Status (9)

Country Link
US (1) US6087349A (da)
EP (1) EP0537007B1 (da)
JP (1) JPH05221866A (da)
AT (1) ATE126059T1 (da)
CA (1) CA2080172A1 (da)
DE (1) DE69204007T2 (da)
DK (1) DK0537007T3 (da)
ES (1) ES2075630T3 (da)
GR (1) GR3017904T3 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312814A (en) * 1992-12-09 1994-05-17 Bristol-Myers Squibb Co. α-phosphonocarboxylate squalene synthetase inhibitors
HUT77406A (hu) * 1994-03-15 1998-04-28 Eisai Co., Ltd., 1-(4-Amino-5-tio-pent-2-en)-il oldalláncot tartalmazó peptidomimetikumok és az ezeket tartalmazó gyógyszerkészítmények
US5436263A (en) * 1994-03-22 1995-07-25 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5420334A (en) * 1994-04-04 1995-05-30 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5510371A (en) * 1994-06-06 1996-04-23 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
US20020034725A1 (en) * 1996-04-15 2002-03-21 W. Gillies Mckenna Sensitization of cells to radiation and and chemotherapy
US6946468B1 (en) 1996-08-17 2005-09-20 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
FR2780974B1 (fr) * 1998-07-08 2001-09-28 Sod Conseils Rech Applic Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
WO2005000858A2 (en) 2003-06-27 2005-01-06 Akira Odani Bisphosphonate complexes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871721A (en) * 1988-01-11 1989-10-03 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors
EP0356866A3 (en) * 1988-08-29 1991-03-27 E.R. SQUIBB & SONS, INC. Phosphorus-containing squalene synthetase inhibitors and method
US5196409A (en) * 1989-08-20 1993-03-23 Yissum, Research Development Company Of The Hebrew University Of Jerusalem Bisphosphonates, pharmaceutical compositions, and process for the treatment of irregularities in calcium metabolism
US5025003A (en) * 1989-09-18 1991-06-18 E. R. Squibb & Sons, Inc. Isoprenoid phosphinylformic acid squalene synthetase inhibitors
US5185248A (en) * 1990-05-08 1993-02-09 E. R. Squibb & Sons, Inc. Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation

Also Published As

Publication number Publication date
DE69204007T2 (de) 1996-03-21
CA2080172A1 (en) 1993-04-12
DE69204007D1 (de) 1995-09-14
EP0537007B1 (en) 1995-08-09
GR3017904T3 (en) 1996-01-31
ATE126059T1 (de) 1995-08-15
ES2075630T3 (es) 1995-10-01
JPH05221866A (ja) 1993-08-31
EP0537007A1 (en) 1993-04-14
US6087349A (en) 2000-07-11

Similar Documents

Publication Publication Date Title
DK0537007T3 (da) Anvendelse af farnesyl-protein-transferase-inhibitorer til fremstilling af et lægemiddel til blokering af neoplastisk transformation af celler fremkaldt af ras-oncogener
FI952010A0 (fi) Farnesyyliproteiinitransferaasin estäjät
FI952011L (fi) Farnesyyliproteiinitransferaasin estäjät
EP0735870A4 (en) Use of pla 2? inhibitors as treatment for alzheimer's disease
NO923908L (no) Fremgangsmaate for inhibering av hydratdannelse
NO941181D0 (no) Heterocykliske inhibitorer for farnesyl-protein-transferase
FI961819A0 (fi) Proteiini:farnesyylitransferaasin substituoidut di- ja tripeptidi-inhibiittorit
DE69303718D1 (de) Verband zur dosierung eines oder mehrerer medikamenten
DE69422907D1 (de) Vorrichtung zum in-line verabreichen einer arznei
DE69221501D1 (de) Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
AU7107496A (en) Protein tyrosine kinase inhibitors for treating osteoarthritis
DE69215818D1 (de) Verfahren zur sicheren Zugangskontrolle
FI945311A7 (fi) Oksibutyniinin transdermaalinen annostelu
NO931947L (no) Fremgangsmaate for korrosjons-hemming
DE69214610D1 (de) Verfahren zur Behandlung von Erdgas
DK130387D0 (da) Transglutaminase inhibitorer
ATE176399T1 (de) Verfahren zur inaktivierung von spermien
DK0537008T3 (da) Anvendelse af bisphosphater til fremstilling af et lægemiddel til blokering af neoplastisk transformation af celle fremkaldt af ras-oncogener
FI944102A0 (fi) Kasvaimen kasvua estämään kykenevä proteiiniyhdiste
KR950701303A (ko) 방향족 비닐 화합물에 대한 중합반응 억제제
DE59202663D1 (de) Verwendung eines UV-Strahlers zur Behandlung von Oberflächen.
BR9104888A (pt) Inibidor e processo para inibicao de polimerizacao de um composto vinila
NO940862D0 (no) Neurotensinfremgangsmåte for inhibering av vaskulær lekkasje
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
DE69208759D1 (de) Salze von N-Nitrosophenylhydroxylamin